We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+25.57%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.4B
AUM Growth
+$5.37B
Cap. Flow
+$508M
Cap. Flow %
2%
Top 10 Hldgs %
19.14%
Holding
1,320
New
149
Increased
490
Reduced
420
Closed
99

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.6M
2
AMZN icon
Amazon
AMZN
+$51.1M
3
EBAY icon
eBay
EBAY
+$50.4M
4
NFLX icon
Netflix
NFLX
+$45.5M
5
RTX icon
RTX Corp
RTX
+$36.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$190M
2
MA icon
Mastercard
MA
+$48.9M
3
RTN
Raytheon Company
RTN
+$44.4M
4
PEP icon
PepsiCo
PEP
+$43.1M
5
SPGI icon
S&P Global
SPGI
+$42M

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Healthcare 19.28%
3 Consumer Discretionary 11.02%
4 Financials 10.21%
5 Industrials 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TENB icon
451
Tenable Holdings
TENB
$3.47B
$8.7M 0.03%
291,746
+113,800
+64% +$3.09M
NTRA icon
452
Natera
NTRA
$36.4B
$8.66M 0.03%
173,671
+63,260
+57% +$2.54M
TMDX icon
453
Transmedics
TMDX
$2.7B
$8.62M 0.03%
481,229
+267,027
+125% +$4.18M
MNTA
454
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8.61M 0.03%
258,812
-25,727
-9% -$819K
ICLR icon
455
Icon
ICLR
$13.7B
$8.59M 0.03%
51,000
-2,975
-6% -$469K
QDEL icon
456
QuidelOrtho
QDEL
$1.13B
$8.55M 0.03%
38,200
+28,700
+302% +$4.5M
ENOV icon
457
Enovis
ENOV
$1.74B
$8.5M 0.03%
+177,031
New +$7.82M
TPTX
458
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$8.5M 0.03%
131,617
-12,809
-9% -$739K
PPLI
459
People Inc
PPLI
$3.12B
$8.41M 0.03%
145,587
-2,182
-1% -$96.9K
PDCO
460
DELISTED
Patterson Companies, Inc.
PDCO
$8.35M 0.03%
379,600
+32,300
+9% +$566K
XYL icon
461
Xylem
XYL
$28.5B
$8.34M 0.03%
128,334
-218,842
-63% -$14.4M
CDW icon
462
CDW
CDW
$18.9B
$8.32M 0.03%
71,649
-36,060
-33% -$3.91M
PRSP
463
DELISTED
Perspecta Inc. Common Stock
PRSP
$8.29M 0.03%
356,894
+98,800
+38% +$2.15M
YMAB
464
DELISTED
Y-mAbs Therapeutics
YMAB
$8.25M 0.03%
191,025
-51,255
-21% -$1.94M
MSI icon
465
Motorola Solutions
MSI
$72.1B
$8.22M 0.03%
58,688
+28,903
+97% +$4.09M
SAIL
466
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$8.21M 0.03%
310,000
XRX icon
467
Xerox
XRX
$345M
$8.19M 0.03%
535,919
-57,713
-10% -$996K
BLUE
468
DELISTED
bluebird bio
BLUE
$8.16M 0.03%
+10,318
New +$7.78M
ZD icon
469
Ziff Davis
ZD
$2B
$8.13M 0.03%
148,005
+18,975
+15% +$1.24M
FNF icon
470
Fidelity National Financial
FNF
$14.4B
$8.11M 0.03%
274,971
-408,340
-60% -$11.2M
HES
471
DELISTED
Hess
HES
$8.11M 0.03%
156,444
+552
+0.4% +$25.3K
GH icon
472
Guardant Health
GH
$19.1B
$8.07M 0.03%
99,480
+14,904
+18% +$1.2M
CONE
473
DELISTED
CyrusOne Inc Common Stock
CONE
$8.05M 0.03%
110,672
-10,000
-8% -$712K
NUAN
474
DELISTED
Nuance Communications, Inc.
NUAN
$8.05M 0.03%
318,200
-8,300
-3% -$173K
KGC icon
475
Kinross Gold
KGC
$27.7B
$8.02M 0.03%
1,110,200
+400,800
+56% +$2.6M

Similar funds

Axa's Q2 2020 Portfolio in Review

As of Q2 2020, Axa held 1,320 positions worth $25.4B, up 27% from $20B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q2 2020 filing shows 149 new, 490 increased, 420 reduced and 99 closed positions. Its largest new stake was Exelixis: 820,990 shares worth $19.5M. The largest sale was Linde, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2020 buy was Exelixis: 820,990 shares worth $19.5M.
  • Axa added most to Microsoft in Q2 2020, an estimated $82.6M increase.
  • Axa's biggest Q2 2020 reduction was Linde, cutting an estimated $190M.
  • Axa fully exited Raytheon Company in Q2 2020, selling an estimated $44.4M.
  • Axa's ten largest holdings make up 19% of its $25.4B portfolio in Q2 2020.
  • Axa opened 149 new positions and closed 99 in Q2 2020.
  • Axa's portfolio value rose 27% quarter-over-quarter to $25.4B.

Based on Axa's 13F filing for Q2 2020, filed 14 Aug 2020.